3 курс / Общая хирургия и оперативная хирургия / Федченко_Я_О_Применение_методов_рентгенохирургии_в_лечении_ТЭЛА
.pdf41.Савельев В.С. Показания к операции и техника хирургического вмешательства при хронической постэмболической легочной гипертензии // Грудная и сердечно-чочудистая хирургия. 1993. - №5. С.
15-19.
42.Савельев В.С., Чазов Е.И., Ильин В.Н. Стрептодеказа в лечении массивной легочной эмболии // Тер. архив – 1982. - №7. –С.94-98.
43.Савельев В.С., Шестаков В.А., Ильин В.Н.. Тромботическое и посттромботическое состояние гемостаза как общебиологическая закономерность тромбообразования // Актуальные проблемы гемостаза, молекулярно-биологические и физиологические аспекты. Под ред. Б.В. Петровского и др. – М.: Наука. – 1979. – С. 83-90.
44.Савельев В.С., Яблоков Е.Г., Кириенко А.И. и др. Легочная гипертензия и объем эмболического поражения сосудистого русла легких // Грудная хирургия. – 1985. – № 3. – С. 10-15.
45.Савельев В.С., Яблоков Е.Г., Кириенко А.И., Массивная эмболия легочных артерий. – М.: Медицина, 1990.
46.Савельев В.С., Яблоков Е.Г., Прокубовский В.И. и др. Профилактика тромбоэмболии легочной артерии методом чрескожной имплантации кава-фильтра РЭПТЭЛА // Грудная и сердечно-сосудистая хирургия.
1990. №1. –С..23-26.
47.Савельев В.С., Яблоков Е.Г., Прокубовский В.И., Капранов С.А. и др. Эндоваскулярная катетерная тромбэктомия из нижней полой вены. Ангиол и сосуд хир 2000; 6: 1: 61-71. 5)
48.Флебология / Под ред В.С. Савельева. М.: Медицина, 2001. 660 с.
49.Чазов Е.И. Тромбозы и эмболии в клинике внутренних болезней. – М.: Медицина. 1996.
50.Чазов Е.И., Лакин К.М. Антикоагулянты и фибринолитические средства.
– М.: Медицина. – 1977.
51.Шакиров Р.Г., Фокин А.А., Владимирский В.В. и др. Хирургическая профилактика тромбоэмболии легочной артерии кава-фильтром ФИРХ //
111
Материалы хирургического общества Пирогова. – 1992. – Заседание
1908.
52.Яблоков Е.Г., Прокубовский В.И., Кириенко А.И. и др. Легочная гипертензия эмболического генеза // Легочная гипертензия при хронических неспецифических заболеваниях легких. – Л.: ВНИИ пульмонологии МЗ СССР. – 1988. – С.59-66.
53.Яковлев В.Б. Проблема тромбоэмболии легочной артерии: пути ее решения в многопрофильном клиническом стационаре // Военно-
медицинский журнал. – 1994. - №10. –С. 25-33.
54.Яковлев В.Б., Абрамов А.Н., Соколянский Н.В. Диагностика и лечение рецидивирующей тромбоэмболии легочной артерии // Сборник резюме 4 Национального конгресса по болезням органов дыхания. – 1994. –
Москва. - № 636.
55.Яковлев В.Б., Яковлева М.В., Венозные тромбоэмболические осложнения: диагностика, лечение, профилактика. //Рос. Мед. Вести –
2002. - № 2.
56.Яковлев В.Б., Яковлева М.В. Тромбоэмболия легочной артерии: патофизиология, диагностика, лечебная тактика // Consilium Medicum. —
2005. — № 6.
57.Achard F., De Laungenhagen B. Embolie Pulmonaire Aique. 5 – Traitement medical // Inform. Cardiol. – 1981. – Vol. 5, N 5. – P. 431-442.
58.Adams J.T., De Weese J/A/ Comparative evaluation of ligation and partial interruption of the femoral vein in the treatment of thromboembolic disease // Ann.Surg. – 1970. – Vol.172. – P. 795-803.
59.Agnelli G. Anticoagulation in the prevention and treatment of pulmonary embolism // Chest. -1995/- Vol.107, N 1. –Suppl.- P. 39-44.
60.Anderson D., Levin M. Thrombolytic therapy for the treatment of acute pulmonary embolism // Can. Med. Assoc. J. – 1992. – Vol.146. P.1317-1324.
61.Anderson F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein
112
thrombosis and pulmonary embolism. The Worcester DVT study //
Arch.Intern.Med. – 1991.- Vol. 151. – P.933-938.
62.Araoz PA, Gotway MB, Harrington JR, Harmsen WS, Mandrekar JN. Pulmonary embolism: prognostic CT findings. Radiology. 2007;242: 889897.
63.Au V.W., Jones D.N., Slavotinek J.P. Pulmonary hypertension secondary to left-sided heart disease: a cause for ventilationperfusion mismatch mimicking pulmonary embolism // Brit. J. Radiology. 2001. Vol. 74. № 877. P.
86-88.
64.Auger W.R., Channick R.N., Kerr K.M., Fedullo P.F. Evaluation of patients with suspected chronic thromboembolic pulmonary hypertension // Semin Thorac Cardiovasc Surg. 1999. Vol. 11, № 2. P. 179-190.
65.Aujesky D, Perrier A, Roy PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med.
2007;261:597-604.
66.Barst RJ, Langleben D, Badesch D, et al. Treatment of pulmonary arterial hypertension with the selective endothelin- A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006;47:2049-2056.
67.Becattini C, Agnelli G. Acute pulmonary embolism: risk stratification in the emergency department Intern Emerg Med. 2007;2:119-129.
68.Becattini C, Agnelli G. Predictors of mortality from pulmonary embolism and their influence on clinical management. Thromb Haemost. 2008;100:747-751.
69.Beek E.J.R., Reekers J.A.,Batchelor D.A., et al. Feasibility, safety and clinical utility of angiography in patients with suspected pulmonary embolism and non-diagnostic lung scan findings (abstr.) // Eur. Radiol. – 1995/ Vol. 5 –P. S82.
70.Bloch P., Schandevyl W., Cham B., et al. Recurrent pulmonary embolism: importance, diagnosis, management and prevention // Acta Chir. Belg. – 1986. – Vol. 86. – P. 109-117.
113
71.Bonderman D, Skoro-Sajer N, Jakowitsch J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007;115:2153-2158.
72.Bonderman D, Wilkens H, Wakounig S, Schafers HJ, Jansa P, Lindner J, Simkova I, Martischnig AM, Dudczak J, Sadushi R, Skoro-Sajer N, Klepetko W, Lang IM. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009; 33:325-331.
73.Brady A.J.B., Crake T., Oakley C. M. Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus // Lancet. – 1991. Vol. 338. – P. 1186-1189.
74.Brandjes D., Heijboer H., Buller H., et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal vein thrombosis // N. Engl. J. Med. – 1992. Vol. 327. – P. 1485-89.
75.Brunn H.D. Heparin – Streptokinase oder operative Therapie bei manifesten thromboembolischen Erkrahkungen // Med. Welt. – 1982. – Bd. 33, N 2. – S. 51/62-57/65.
76.Casaclang-Verzosa G, McCully RB, Oh JK, Miller FA Jr, McGregor CG. Effects of pulmonary thromboendarterectomy on right-sided echocardiographic parameters in patients with chronic thromboembolic pulmonary hypertension. Mayo Clin Proc 2006;81:777-782.
77.Cavallazzi R, Nair A, Vasu T, Marik PE. Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med.
2008;34:2147-2156.
78.Cervera-Caballos J., Sakinis A., Titus J., et al. Experimental pulmonary embolectomy (abstr) // Cardiovasc. Intervent. Radiol. – 1994. – Vol. 17 (suppl 2). – S 120.
79.Chaouat A., Weitzenblum E., Higenbottam T. The role thrombosis in severe pulmonary hypertension // Eur. Respir. J.- 1996. – Vol. 9. – P. 356-363.
114
80.Cina G., Marra R., Di Stasi C., Macis G. Epidemiology, pathophisiology and natural history of venous thromboembolism. // Rays. – 1996. – Vol. 21, N 3. –
P.315-327.
81.Cohen A.T., Edmondson R.A., Phillips M.J., Ward V.P., Kakkar V.V. The changing pattern of venous thromboembolic disease. // Haemostasis. – 1996.
– Vol. 26, N 2. – P. 65-71.
82.Collins R., Scrimgeour A., Yusuf S., et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic and urologic surgery // N. Engl. J. Med. – 1988. – Vol. 318. – P. 1162-1173.
83.Condliffe R, Kiely DG, Gibbs JS, et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J 2009; 33: 332–338.
84.Corsico AG, D’Armini AM, Cerveri I, et al. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 2008;178:419-424.
85.Cournand A. The historical development of the concepts of pulmonary circulation // In: Pulmonary circulation. An international symposium, 1958. – Ed.: Adams R. W., Veith I. – New-York London. - Grune & Stratton. - 1959.
P.1-19.
86.Coutance G, Le Page O, Lo T, Hamon M. Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Crit Care. 2008;12:R109.
87.Daily O.P. Chronic pulmonary embolism // General Thoracic Surgery / Eds. F.G. Pearson, D.J. Ginsberg, R.J. Hiebert, C.A. McKneally. – 1st ed. – Philadelphia: Churchill Livingston, 1995. –P. 597-611.
88.Darryl Y. Sue, MD (ed.): Pulmonary Disease. In Frederic S. Dongard, MD (ed.): Current: Critical Care Diagnosis & Treatment – US – a lange medical book. – First Edition. – p. 496.
89.Dartevelle P., Fadel E., Chapelier A. et al. Pulmonary thromboendarterectomy
with video-angioscopy and circulatory arrest: an alternative to
115
cardiopulmonary transplantation and postembolism pulmonary artery
hypertension // Chirurgie. – 1998. –Vol. 123. – P. 32-40.
90.Dartevelle P., Fadel E., Mussot S. et al. Chronic thromboembolic pulmonary hypertension // Eur. Respir. J. – 2004. – Vol. 23. –P. 637-648.
91.David M., Andrew M. Venous thromboembolic complications in children // J. Pediatr. -1993. Vol. 123, N. 3. – P. 337-345.
92.Dentali F, Donadini M, Gianni M, et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res 2009;124: 256-258.
93.Donze J, Le Gal G, Fine M, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008;100:943-948.
94.Eftychiou V. Clinical diagnosis and management of the patient with deep veneus thromboembolism and acute pulmonary embolism. // Nurse Pract. – 1996. – Vol. 21. N 3. – P. 50-62.
95.Erol C., Candan I. Non-invasive methods in the diagnosis of chronic majorvessel thromboembolic pulmonary hypertension // Eur. Heart J. 1993.
Vol. 14, № 7. P. 1004-1005.
96. Essop M.R., Middlemost S., Skoularigis J., Sareli P. Simultaneous mechanical clot fragmentation and pharmacologic thrombolysis in acute massive pulmonary embolism // Amer. J. Cardiol.- 1992.- Vol. 69. – P. 427430.
97.Fava M., Loyola M., Flores P., Huete I. Pharmacologic thrombolysis and mechanical fragmentation in massive pulmonary embolism (abstr) // JVIR. - 1996. – Vol. 7., N 1, part 2 (suppl). – P. S245.
98.Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension // New Engl. J. Med. 2001. № 345. P. 14651472.
116
99.Ferrary E., Baudouy M., Cerbony P. et al. Clinical epidemiology of venous thromboembolic disease. Results of a French Multicentre Registry. // European Heart Journal. – 1997. – Vol. 349. – P. 685 – 691.
100.Fremont B, Pacouret G, Jacobi D, Puglisi R Charbonnier B, de Labriolle A. Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest. 2008;133:358-362.
101.Galiè N, Brundage BH, Ghofrani HA, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009;119: 2894-2903.
102.Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Sandset PM. The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE. J Intern Med. 2007;261:74-81.
103.Ghaye B, Ghuysen A, Bruyere PJ, D'Orio V, Dondelinger RF. Can CT pulmonary angiography allow assessment of severity and prognosis in patients presenting with pulmonary embolism? What the radiologist needs to know. Radiographics. 2006;26:23-40.
104.Gibson N, Sohne M, Buller H. Prognostic value of echocardiography and spiral computer tomography in patients with pulmonary embolism. Curr Opin Pulm Med. 2006;11:380-384.
105.Giorgetti P.L., Arpesani A., Mattioli A. et al. The surgical prevention of pulmonary embolism. Comments on 100 patients treated by different methods. // Minerva Chir. – 1991. – Vol. 46, N 19. – P. 1005-1014.
106.Goldhaber S.Z. Evolving concepts in thrombolytic therapy for pulmonary embolism // Chest. – 1992. – Vol. 101 (suppl). – P. 183-185S.
107.Goldhaber S.Z., Morpugo M. Diagnosis, treatment and prevention of pulmonary embolism. Report of the WHO/International Society and federation of Cardiology Task Force// JAMA. – 1992. – Vol. 268. – P. 17271733.
117
108.Goldhaber S.Z., Vizani L., De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry // Lancet. 1999. № 353. P. 1386-1389.
109.Goldhaber S.Z/ Clinical overview of venous thromboembolism. // Vasc. Med.
–1998. – Vol. 3, N 1. – P. 35-40.
110.Gray H.H., Firoozan S. Management of pulmonary embolism // Thorax. – 1992. – Vol. 47. – P. 825-832.
111.Haskal Z., Soulen M., Huettl E., et al. Life-threatening pulmonary emboli and cor pulmonale: treatment with percutaneous pulmonary artery stent placement // Radiology. – 1994. Vol.191. – P. 473-475.
112.Heinrich F., Klink K. Lungenembolie. – Berlin: Springer-Verlag, 1984, 149 s.
113.Hillum R.F. Pulmonary embolism and thrombophlebitis in the United States, 1970-1985 // Am. Heart J. – 1987.- Vol. 144. – P. 1261-1264.
114.Hirsh J. Antithrombotic therapy in deep vein thrombosis and pulmonary embolism // Am. Heart. J. – 1992. – Vol. 123. – P. 1115-1122.
115.Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011-2020.
116.Hsu JT, Chu CM, Chang ST, et al. Prognostic value of arterial/alveolar oxygen tension ratio (a/APO2) in acute pulmonary embolism. Circ J.
2007;71:1560-1566.
117.Huisman M.V., Buller H.R., Cate J.W., et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis // Chest.
–1989. – Vol. 95. – P. 498-502.
118.Hull R., Hirsh J., Jay R., et al. Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis // N. Engl. J. Med. – 1982. – Vol. 307. – P. 1676-1681.
119.Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. EurRespir Rev 2010; 19: 59–63.
118
120.Iino M, Dymarkowski S, Chaothawee L, Delcroix M, Bogaert J. Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism. Eur Radiol 2008;18:792-799.
121.Jais X, D'Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, Hoeper MM, Lang IM, Mayer E, Pepke-Zaba J, Perchenet L, Morganti A, Simonneau G, Rubin LJ. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebocontrolled trial. J Am Coll Cardiol 2008;52:2127-2134.
122.Jeffery P.C., Nicolaides A.N. Graguated compression stockings in the prevention of postoperative deep vein thrombosis // Br. J. Surdg. – 1990. – Vol. 77. – P. 380-383.
123.Jensen KW, Kerr KM, Fedullo PF, et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 2009;120: 1248-1254.
124.Kakkar V.V., Thomas D.D., ed. Heparin chemistry and clinical usage. – London: Academic press. – 1976.
125.Katsamouris A., Waltman A., Delichatsios M., Athanasoulis C. Inferior vena cava filters: in vitro comparison of clot trapping and flow dynamics // Radiology. – 1988. – Vol. 166. – P. 361-366.
126.Kearon C, Kahn SR, Agnelli G, Goldhaber SZ, Raskob GE, Comerota AJ. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest.
2008;133:454S-545S.
127.Keogh AM, Mayer E, Benza RL, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl. 1, S67–S77.
128.Kerr C., Yan L. Pulmonary embolism: clinical decision making to increase diagnostic accuracy // Postgrad. Med. – 1992. – Vol. 91. – P. 73-86.
119
129.Kim NH. Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension? Eur Respir Rev 2010;19:68-71.
130.Kline JA, Steuerwald MT, Marchick MR, et al. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest 2009;136:1202-1210.
131.Kominami S, Tanabe N, Ota M, et al. HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis. J Hum Genet 2009;54:108-114.
132.Kreitner KF, Kunz RP, Ley S, et al. Chronic thromboembolic pulmonary hypertension — assessment by magnetic resonance imaging. Eur Radiol 2007;17: 11-21.
133.Kurzyna M., Torbicki A., Pruszczyk V. et al. Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism // Amer. J. Cardiology. – 2002. – Vol. 90, № 5. – P. 507-511.
134.Lang IM. Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options.EurRespir Rev 2009; 18: 24–28.
135.Leu H.J. Histologische Alterbestimmung von arteriellen und venosen Thromben und Emboli. // Vasa. – 1973. – Vol. 2. – P. 265-273.
136.Li JH, Safford RE, Aduen JF, et al. Pulmonary hypertension and thyroid disease. Chest 2007;132:793-797.
137.Lopez-Majano V. Диагностика тромбоэмболической болезни (пер. с англ.) // В сб.: Эндоваскулярные методы лечения в пульмонологии. Под ред. Путов Н.В., Некласов Ю.Ф. – С-Петербург. – 1992. – С. 49-58.
138.Manier G., Castaing Y. Infiuence of cardiac output on oxygen exchange in acute pulmonary embolism // Am. Rev. Respir. Dis. – 1992. – Vol. 145.- P. 130-136.
139.Matsuda H, Ogino H, Minatoya K, et al. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006;82:1338-1343.
120